Tumor-derived exosomes educate dendritic cells to promote tumor metastasis via HSP72/HSP105-TLR2/TLR4 pathway

References

• Gilboa E. DC-based cancer vaccines. J Clin Invest. 2007;117:1195-203. doi:10.1172/JCI31205. PMID:17476349
   PubMed Web of Science ®Google Scholar
• Hargadon KM. The extent to which melanoma alters tissue-resident dendritic cell function correlates with tumorigenicity. Oncoimmunology. 2016;5:e1069462. doi:10.1080/2162402X.2015.1069462. PMID:26942090
   PubMed Web of Science ®Google Scholar
• Tesone AJ, Rutkowski MR, Brencicova E, Svoronos N, Perales-Puchalt A, Stephen TL, Allegrezza MJ, Payne KK, Nguyen JM, Wickramasinghe J, et al. Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells. Cell Rep. 2016;14:1774-86. doi:10.1016/j.celrep.2016.01.056. PMID:26876172
   PubMed Web of Science ®Google Scholar
• Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004;5:987-95. doi:10.1038/ni1112. PMID:15454922
   PubMed Web of Science ®Google Scholar
• Tang CH, Chen CF, Chen WM, Fong YC. IL-6 increases MMP-13 expression and motility in human chondrosarcoma cells. J Biol Chem. 2011;286:11056-66. doi:10.1074/jbc.M110.204081. PMID:21278254
   PubMed Web of Science ®Google Scholar
• Dohadwala M, Luo J, Zhu L, Lin Y, Dougherty GJ, Sharma S, Huang M, Pold M, Batra RK, Dubinett SM. Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J Biol Chem. 2001;276:20809-12. doi:10.1074/jbc.C100140200. PMID:11320076
   PubMed Web of Science ®Google Scholar
• Sheng KC, Pietersz GA, Wright MD, Apostolopoulos V. Dendritic cells: activation and maturation–applications for cancer immunotherapy. Curr Med Chem. 2005;12:1783-800. doi:10.2174/0929867054367248. PMID:16029147
   PubMed Web of Science ®Google Scholar
• Verhasselt V, Buelens C, Willems F, De Groote D, Haeffner-Cavaillon N, Goldman M. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J Immunol. 1997;158:2919-25. PMID:9058830
   PubMed Web of Science ®Google Scholar
• Monrad SU, Kojima F, Kapoor M, Kuan EL, Sarkar S, Randolph GJ, Crofford LJ. Genetic deletion of mPGES-1 abolishes PGE2 production in murine dendritic cells and alters the cytokine profile, but does not affect maturation or migration. Prostaglandins Leukot Essent Fatty Acids.. 2011;84:113-21. doi:10.1016/j.plefa.2010.10.003. PMID:21190819
   PubMed Web of Science ®Google Scholar
• Tkach M, Thery C. Communication by Extracellular Vesicles: Where We Are and Where We Need to Go. Cell. 2016;164:1226-32. doi:10.1016/j.cell.2016.01.043. PMID:26967288
   PubMed Web of Science ®Google Scholar
• Liu Y, Gu Y, Cao X. The exosomes in tumor immunity. Oncoimmunology. 2015;4:e1027472. doi:10.1080/2162402X.2015.1027472. PMID:26405598
   PubMed Web of Science ®Google Scholar
• Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med. 2001;7:297-303. doi:10.1038/85438. PMID:11231627
   PubMed Web of Science ®Google Scholar
• Dai S, Wan T, Wang B, Zhou X, Xiu F, Chen T, Wu Y, Cao X. More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells. Clin Cancer Res. 2005;11:7554-63. doi:10.1158/1078-0432.CCR-05-0810. PMID:16243831
   PubMed Web of Science ®Google Scholar
• Xiang X, Poliakov A, Liu C, Liu Y, Deng ZB, Wang J, Cheng Z, Shah SV, Wang GJ, Zhang L, et al. Induction of myeloid-derived suppressor cells by tumor exosomes. Int J Cancer. 2009;124:2621-33. doi:10.1002/ijc.24249. PMID:19235923
   PubMed Web of Science ®Google Scholar
• Lewis AM, Varghese S, Xu H, Alexander HR. Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med. 2006;4:48. doi:10.1186/1479-5876-4-48. PMID:17096856
   PubMed Web of Science ®Google Scholar
• Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer. 2007;121:2373-80. doi:10.1002/ijc.23173. PMID:17893866
   PubMed Web of Science ®Google Scholar
• Liao Q, Zeng Z, Guo X, Li X, Wei F, Zhang W, Li X, Chen P, Liang F, Xiang B, et al. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation. Oncogene. 2014; 33, 2098–109. doi:10.1038/onc.2013.161. PMID:23708661
   PubMed Web of Science ®Google Scholar
• Sun Q, Liu Q, Zheng Y, Cao X. Rapamycin suppresses TLR4-triggered IL-6 and PGE(2) production of colon cancer cells by inhibiting TLR4 expression and NF-kappaB activation. Mol Immunol. 2008;45:2929-36. doi:10.1016/j.molimm.2008.01.025. PMID:18343502
   PubMed Web of Science ®Google Scholar
• Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161-74. doi:10.1038/nrc745. PMID:11990853
   PubMed Web of Science ®Google Scholar
• Gu FM, Li QL, Gao Q, Jiang JH, Zhu K, Huang XY, Pan JF, Yan J, Hu JH, Wang Z, et al. IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma. Mol Cancer. 2011;10:150. doi:10.1186/1476-4598-10-150. PMID:22171994
   PubMed Web of Science ®Google Scholar
• Liu Q, Li G, Li R, Shen J, He Q, Deng L, Zhang C, Zhang J. IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines. J Neurooncol. 2010;100:165-76. doi:10.1007/s11060-010-0158-0. PMID:20361349
   PubMed Web of Science ®Google Scholar
• Hou CH, Hsiao YC, Fong YC, Tang CH. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13. Bone. 2009;44:233-42. doi:10.1016/j.bone.2008.09.021. PMID:19038372
   PubMed Web of Science ®Google Scholar
• Akira S. IL-6-regulated transcription factors. Int J Biochem Cell Biol. 1997;29:1401-18. doi:10.1016/S1357-2725(97)00063-0. PMID:9570135
   PubMed Web of Science ®Google Scholar
• Aaronson DS, Horvath CM. A road map for those who don't know JAK-STAT. Science. 2002;296:1653-5. doi:10.1126/science.1071545. PMID:12040185
   PubMed Web of Science ®Google Scholar
• Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335-76. doi:10.1146/annurev.immunol.21.120601.141126. PMID:12524386
   PubMed Web of Science ®Google Scholar
• Vabulas RM, Wagner H, Schild H. Heat shock proteins as ligands of toll-like receptors. Curr Top Microbiol. 2002;270:169-84. doi:10.1007/978-3-642-59430-4_11. PMID:12467251
   PubMed Web of Science ®Google Scholar
• Chen TY, Guo J, Yang MJ, Zhu XH, Cao XT. Chemokine-Containing Exosomes Are Released from Heat-Stressed Tumor Cells via Lipid Raft-Dependent Pathway and Act as Efficient Tumor Vaccine. J Immunol. 2011;186:2219-28. doi:10.4049/jimmunol.1002991. PMID:21242526
   PubMed Web of Science ®Google Scholar
• Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin JP, Boireau W, Rouleau A, Simon B, Lanneau D, et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest. 2010;120:457-71. doi:10.1172/JCI40483. PMID:20093776
   PubMed Web of Science ®Google Scholar
• Galloway E, Shin T, Huber N, Eismann T, Kuboki S, Schuster R, Blanchard J, Wong HR, Lentsch AB. Activation of hepatocytes by extracellular heat shock protein 72. Am J Physiol Cell Physiol. 2008;295:C514−20. doi:10.1152/ajpcell.00032.2008. PMID:18508912
   PubMed Web of Science ®Google Scholar
• Yamagishi N, Fujii H, Saito Y, Hatayama T. Hsp105beta upregulates hsp70 gene expression through signal transducer and activator of transcription-3. FEBS J. 2009;276:5870-80. doi:10.1111/j.1742-4658.2009.07311.x. PMID:19754877
   PubMed Web of Science ®Google Scholar
• Ridgway D. The first 1000 dendritic cell vaccinees. Cancer Invest. 2003;21:873-86. doi:10.1081/CNV-120025091. PMID:14735692
   PubMed Web of Science ®Google Scholar
• Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer. 2012;12:265-77. doi:10.1038/nrc3258. PMID:22437871
   PubMed Web of Science ®Google Scholar
• Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari N, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015;523:177-82. doi:10.1038/nature14581. PMID:26106858
   PubMed Web of Science ®Google Scholar
• Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med. 2001;7:297-303. doi:10.1038/85438. PMID:11231627
   PubMed Web of Science ®Google Scholar
• Mignot G, Roux S, Thery C, Segura E, Zitvogel L. Prospects for exosomes in immunotherapy of cancer. J Cell Mol Med. 2006;10:376-88. doi:10.1111/j.1582-4934.2006.tb00406.x. PMID:16796806
   PubMed Web of Science ®Google Scholar
• Rao Q, Zuo B, Lu Z, Gao X, You A, Wu C, Du Z, Yin H. Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and human in vitro. Hepatology. 2016; 64, 456–72. doi:10.1002/hep.28549. PMID:26990897
   PubMed Web of Science ®Google Scholar
• Koh E, Lee EJ, Nam GH, Hong Y, Cho E, Yang Y, Kim IS. Exosome-SIRPalpha, a CD47 blockade increases cancer cell phagocytosis. Biomaterials. 2017;121:121-9. doi:10.1016/j.biomaterials.2017.01.004. PMID:28086180
   PubMed Web of Science ®Google Scholar
• Whiteside TL. Exosomes and tumor-mediated immune suppression. J Clin Invest. 2016;126:1216-23. doi:10.1172/JCI81136. PMID:26927673
   PubMed Web of Science ®Google Scholar
• Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang HY, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17:816-26. doi:10.1038/ncb3169. PMID:25985394
   PubMed Web of Science ®Google Scholar
• Liu CR, Yu SH, Zinn K, Wang JH, Zhang LM, Jia YJ, Kappes JC, Barnes S, Kimberly RP, Grizzle WE, et al. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol. 2006;176:1375-85. doi:10.4049/jimmunol.176.3.1375. PMID:16424164
   PubMed Web of Science ®Google Scholar
• Clayton A, Mitchell JP, Court J, Linnane S, Mason MD, Tabi Z. Human tumor-derived exosomes down-modulate NKG2D expression. J Immunol. 2008;180:7249-58. doi:10.4049/jimmunol.180.11.7249. PMID:18490724
   PubMed Web of Science ®Google Scholar
• Wang YZ, Yi J, Chen XG, Zhang Y, Xu M, Yang ZX. The regulation of cancer cell migration by lung cancer cell-derived exosomes through TGF-beta and IL-10. Oncol Lett. 2016;11:1527-30. doi:10.3892/ol.2015.4044. PMID:26893774
   PubMed Web of Science ®Google Scholar
• Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res. 2007;67:7458-66. doi:10.1158/0008-5472.CAN-06-3456. PMID:17671216
   PubMed Web of Science ®Google Scholar
• Zhang MH, Tang H, Guo ZH, An HZ, Zhu XJ, Song WG, Guo J, Huang X, Chen T, Wang J, et al. Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat Immunol. 2004;5:1124-33. doi:10.1038/ni1130. PMID:15475957
   PubMed Web of Science ®Google Scholar
• Cai Z, Zhang W, Yang F, Yu L, Yu Z, Pan J, Wang L, Cao X, Wang J. Immunosuppressive exosomes from TGF-beta1 gene-modified ?dendritic cells attenuate Th17-mediated inflammatory autoimmune disease by inducing regulatory T cells. Cell Res. 2012;22:607-10. doi:10.1038/cr.2011.196. PMID:22157651
   PubMed Web of Science ®Google Scholar
• Baillat D, Hakimi MA, Naar AM, Shilatifard A, Cooch N, Shiekhattar R. Integrator, a multiprotein mediator of small nuclear RNA processing, associates with the C-terminal repeat of RNA polymerase II. Cell. 2005;123:265-76. doi:10.1016/j.cell.2005.08.019. PMID:16239144
   PubMed Web of Science ®Google Scholar